METTLER TOLEDO proudly announces the world's first traceable, combined density and refractive index standards. The four standard substances, certified for both density value and refractive index can be used to certify or verify density and refractive index instruments or combined measurement systems. Certification or verification is often required by quality management standards such as GMP (Good Manufacturing Practice) or ISO 17025. (PRWeb Aug 30, 2009)
Read the full story at http://www.prweb.com/releases/2009/08/prweb2806164.htm
¶ 5:20 PM 0 comments
Stemedica Cell Technologies, Inc. USA, a leader in adult stem radiophone research and manufacturing, has requested a pre-Investigational New Drug (IND) meeting with the U.S. Food and Drug Administration ("FDA") to discuss a proposed IND to use Stemedica's proprietary line of allogeneic mesenchymal bone marrow cells (adult human) as a treatment for ischemic stroke. (PRWeb Aug 21, 2009)
Read the full story at http://www.prweb.com/releases/Stemedica-Stroke/PRE-IND-FDA/prweb2776804.htm
¶ 5:20 AM 0 comments
HCL Innovations will market and redistribute anhydrous HCl obtained from Formosa Plastics (PRWeb Aug 20, 2009)
Read the full story at http://www.prweb.com/releases/Anhydrous_Hydrogen/Chloride/prweb2772764.htm
¶ 5:20 PM 0 comments
Offering consumers a new pick in personal care ointments. (PRWeb Aug 19, 2009)
Read the full story at http://www.prweb.com/releases/2009/Holistic_Health/prweb2766394.htm
¶ 5:20 AM 0 comments
Needham Heights, Massachusetts, August, 2009 - Polestar Technologies, a leader in optical sensor technologies, has engaged FCx Performance to provide sales and distribution support in New England. Polestar has a full line of optical sensors for pH and dissolved oxygen to meet the needs of the pharmaceutical, biotechnology, food and beverage, brewing, environmental and pure water industries. Demand for Polestar optical sensors is increasing dramatically, particularly in the biopharma and single-use bio-processing markets. These markets are expected to grow at more than 25% per year over the next 5 years. FCx Performance provides a highly skilled team with deep experience in this marketplace and will help Polestar take advantage of this market opportunity. (PRWeb Aug 9, 2009)
Read the full story at http://www.prweb.com/releases/2009/08/prweb2728894.htm
¶ 5:20 AM 0 comments
The Nursing Home Complaint Center Wants To Talk With Law Firms In California, Florida and Texas That Have A Passion For Elder Abuse
The Nursing Home Complaint Center was created by one of the nation's leading advocacy groups in order to educate the average US citizen about elder abuse, especially when it comes to our nation's nursing homes, and at the same time help victims or their families find high quality law firms in the top 100 US metro areas, to assist the victim or the family ascertain if there might be an elder abuse issue.
At the same time, the Nursing Home Complaint Center will investigate Medicare & Medicaid fraud, possible nursing home class action issues, etc. The Nursing Home Complaint Center would like to hear from law firms in larger metro areas of California, Florida and Texas that might have an interest in helping the victims of nursing home abuse.
For a law firm with an elder abuse practice, this is a win-win situation. For more information lawyers or law firms can contact the Nursing Home Complaint Center anytime at 866-714-6466, or contact the group via its web site at Http://NursingHomeComplaintCenter.Com. (PRWeb Aug 6, 2009)
Read the full story at http://www.prweb.com/releases/2009/08/prweb2723234.htm
¶ 5:20 PM 0 comments
METTLER TOLEDO, a leading global supplier of precision instruments, is pleased to introduce a pH kit specific to the pharmaceutical industry. The S40P pH meter is a complete kit that combines the S40 SevenMulti pH meter, an InLab® Routine Pro electrode and all the necessary cables and buffer standards ideal for running samples in the pharmaceutical industry. (PRWeb Aug 2, 2009)
Read the full story at http://www.prweb.com/releases/2009/08/prweb2706104.htm
¶ 5:20 PM 0 comments